Achieving Launch Excellence in Asia-Pacific Transcript ... - IMS Health
Achieving Launch Excellence in Asia-Pacific Transcript ... - IMS Health
Achieving Launch Excellence in Asia-Pacific Transcript ... - IMS Health
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ural markets. MNCs can also meet the challenge by partner<strong>in</strong>g with local<br />
manufacturers and suppliers and seek<strong>in</strong>g possible tax exemptions.<br />
That’s an <strong>in</strong>terest<strong>in</strong>g po<strong>in</strong>t. So apply<strong>in</strong>g the three As is crucial when<br />
launch<strong>in</strong>g <strong>in</strong> APAC. What assistance is there for companies available<br />
from <strong>IMS</strong> HEALTH?<br />
Well, <strong>IMS</strong> HEALTH is well positioned to help MNCs avoid common pitfalls and<br />
strengthen the three Foundational Success factors of determ<strong>in</strong><strong>in</strong>g and optimis<strong>in</strong>g<br />
their product’s value proposition, effectively and efficiently engag<strong>in</strong>g<br />
stakeholders, mapp<strong>in</strong>g out resource allocation and monitor<strong>in</strong>g and driv<strong>in</strong>g<br />
performance, as well as align<strong>in</strong>g and prepar<strong>in</strong>g these organisations for launch.<br />
I see. You mentioned common pitfalls just now. Can you give us some<br />
examples of what these typically are?<br />
Yes, certa<strong>in</strong>ly. What we see often is that companies don’t tend to learn from past<br />
launch mistakes not just <strong>in</strong> target<strong>in</strong>g their audiences better, but also they tend<br />
to under-estimate their own constra<strong>in</strong>ts, they don’t give themselves enough time<br />
to prepare, and don’t adopt a consistent framework to drive the launch execution<br />
process to ensure plans are followed through.<br />
What can happen as a result?<br />
They can fail to get their product listed on formulary, or payers won’t accept<br />
their value proposition, or they could fail to forecast the demand <strong>in</strong> <strong>Asia</strong>, or fail<br />
to drill down to the base of the socio economic pyramid, to the patients, and<br />
understand patients’ capacity to spend on medic<strong>in</strong>es. These are all issues <strong>IMS</strong><br />
HEALTH can help companies avoid.<br />
I suppose companies can also take advantage of <strong>IMS</strong>’ <strong>in</strong>-depth<br />
knowledge of the market they <strong>in</strong>tend to launch, and services to help<br />
them achieve better success as they prepare to launch <strong>in</strong>to those<br />
markets.<br />
Very much so. We are well positioned to assist <strong>in</strong> a number of ways. As you<br />
mentioned, we have deep therapeutic market knowledge and competitive <strong>in</strong>sight<br />
so we can advise on the complex competitive dynamics <strong>in</strong> today’s chang<strong>in</strong>g<br />
markets. Secondly, we can advise on market<strong>in</strong>g approaches to take <strong>in</strong> <strong>in</strong>dividual<br />
markets.<br />
Your analytical tools are also known to be pretty effective.<br />
Yes, us<strong>in</strong>g <strong>IMS</strong> Radar Dynamics, APLD, primary market research and enhanced<br />
promotional audits, we have country-by-country evidence-based <strong>in</strong>sight <strong>in</strong>to<br />
market<strong>in</strong>g tactics and success drivers.<br />
7